Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia

Abstract

These data suggest that exposure to AL in pregnancy, including first trimester, is not associated with particular safety risks in terms of perinatal mortality, malformations, or developmental impairment. However, more data are required on AL use during the first trimester.